PP
QTTB icon

PDT Partners’s Q32 Bio QTTB Stock Holding History

PDT Partners’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-884
Closed -$58K – 1146
2021
Q4 		$58K Buy
+884
New +$85.8K ﹤0.01% 847
2021
Q2 		– Sell
-883
Closed -$150K – 972
2021
Q1 		$150K Buy
883
+149
+20% +$31.4K 0.01% 722
2020
Q4 		$149K Sell
734
-218
-23% -$42.1K 0.01% 636
2020
Q3 		$183K Buy
952
+272
+40% +$61K 0.01% 640
2020
Q2 		$186K Buy
+680
New +$181K 0.01% 599

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

PDT Partners's QTTB Position: Q1 2022 in Review

PDT Partners sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 884 shares — an estimated $58K sold.

PDT Partners first reported a position in QTTB in Q2 2020 and held it in 5 quarters. The position peaked at $186K in Q2 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • PDT Partners reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 884 Q32 Bio shares in Q1 2022, an estimated $58K.
  • PDT Partners first reported a position in Q32 Bio in Q2 2020 and held it in 5 quarters.
  • PDT Partners's Q32 Bio position peaked at $186K in Q2 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.